Capabilities by Region

Greenhill is active in all major markets with meaningful corporate advisory activity, including in North America, Europe,  Asia, and Australia.

Recent Transactions

21-Nov-11
$689 million
Australia flag
Target: 

iNova Pharmaceuticals

United States flag
Acquiror: 
Valeant Pharmaceuticals

Advised Archer Capital and Ironbridge Capital on the sale of iNova Pharmaceuticals, a leading pharmaceuticals company that sells and distributes a range of prescription and over-the-counter products in Australia, New Zealand, Asia and Southern Africa, to Valeant Pharmaceuticals

17-Nov-11
$860 million
United States flag
Target: 

MeadWestvaco’s Consumer & Office Products Division

United States flag
Acquiror: 
ACCO Brands Corporation

Provided fairness opinion to the Board of Directors of MeadWestvaco Corporation on the spin-off and subsequent merger of its Consumer & Office Products Division with ACCO Brands Corporation

17-Nov-11
$1.5 billion
United Kingdom flag
Target: 

Northern Rock

United Kingdom flag
Acquiror: 
Virgin Money

Advised Virgin Money, a financial services provider, on the acquisition of Northern Rock, a UK retail mortgage and savings bank, from UK Financial Investments Ltd, which manages the UK Government’s investments in financial institutions

10-Nov-11
$318 million
Australia flag
Target: 

MSF Sugar

Thailand flag
Acquiror: 
Mitr Phol Group

Advised MSF Sugar, Australia’s third largest producer and second largest exporter of sugar, on an acquisition proposal from Mitr Phol Sugar Corp. of Thailand at an offer value of ~31% premium to previous close

07-Nov-11
$398 million
United States flag
Target: 

American Dental Partners, Inc.

United States flag
Acquiror: 
JLL Partners

Advised American Dental Partners, Inc. (NASD: ADPI), one of the nation’s leading business partners to dental group practices, on its sale to JLL Partners, a leading private equity firm

Pages

show all